Table 7.
Treatment group | Alanine aminotransferase (U/L) | Aspartate aminotransferase (U/L) | Alkaline phosphatase (U/L) | Protein (g/dL) |
---|---|---|---|---|
Normal control | 23.42 ± 1.01e | 55.86 ± 1.47e | 76.91 ± 2.06d | 7.87 ± 0.13a |
Diabetic control | 51.25 ± 1.65a | 100.21 ± 2.12a | 146.88 ± 3.34a | 3.21 ± 0.11d |
DMT | 30.51 ± 1.16c | 63.12 ± 1.26c | 84.14 ± 1.83c | 5.33 ± 0.21b |
D10%MIKF | 33.60 ± 1.91b | 66.28 ± 1.91b | 87.23 ± 2.32b | 5.15 ± 0.16bc |
D20%MIKF | 27.98 ± 1.46d | 60.60 ± 1.57d | 81.68 ± 2.20c | 5.35 ± 0.22b |
Values represent mean ± standard deviation of replicate determinations (n = 5). Values with different superscript letters along the column differ significantly (P < 0.05).
DMT, diabetic rats treated with metformin; D10%MIKF, diabetic rats fed 10% M. indica kernel flour‐supplemented high fat diet (HFD); D20%MIKF, diabetic rats fed 20% M. indica kernel flour‐supplemented HFD.